Hydrochloric Acid

Hydrochloric Acid

SCHEMBL602452

CCCCCCCCCCCC(C)(C)C(N)(O)CC.Cl

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
SMPD1 P17405 5/20 0.43
FDPS P14324 10/20 0.42
GGPS1 O95749 5/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL28423915 0.83 FDPS (0.45) SMPD1FDPSGGPS1
Hydrochloric Acid SCHEMBL27847712 0.82 FDPS (0.48) SMPD1FDPSGGPS1
SCHEMBL7169876 0.80 FDPS (0.47) SMPD1FDPSGGPS1
SCHEMBL4141311 0.80 FDPS (0.50) SMPD1FDPSGGPS1
SCHEMBL6938402 0.80 FDPS (0.50) SMPD1FDPSGGPS1
SCHEMBL28512726 0.80 FDPS (0.50) SMPD1FDPSGGPS1
Hydrochloric Acid SCHEMBL9485806 0.80 FDPS (0.46) SMPD1FDPSGGPS1
SCHEMBL9207157 0.80 FDPS (0.50) SMPD1FDPSGGPS1
SCHEMBL9205361 0.80 FDPS (0.50) SMPD1FDPSGGPS1
SCHEMBL4286298 0.80 FDPS (0.50) SMPD1FDPSGGPS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 601 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3894015-B1 SHAMPOO COMPOSITION COMPRISING SHEET-LIKE MICROCAPSULES PROCTER & GAMBLE (US) 2026-05-20 EP disclosed
EP-4103335-B1 BOTTLE ADAPTED FOR STORING A LIQUID COMPOSITION WITH AN AESTHETIC DESIGN SUSPENDED THEREIN PROCTER & GAMBLE (US) 2026-05-20 EP disclosed
EP-4734909-A1 DISSOLVABLE SOLID CLEANSING ARTICLES CONTAINING SULFONATE-CONTAINING ANIONIC SURFACTANTS The Procter & Gamble Company (US) 2026-05-06 EP disclosed
EP-3663384-B1 PARTICULATE LAUNDRY SOFTENING WASH ADDITIVE PROCTER & GAMBLE (US) 2026-05-06 EP disclosed
EP-3727323-B1 CLEAR SHAMPOO COMPOSITION CONTAINING SILICONE POLYMERS PROCTER & GAMBLE (US) 2026-04-29 EP disclosed
EP-4729046-A2 COMPOSITIONS HAVING ENHANCED DEPOSITION OF SURFACTANT SOLUBLE ANTIDANDRUFF AGENTS The Procter & Gamble Company (US) 2026-04-22 EP disclosed
EP-4337333-B1 SHAMPOO COMPOSITION PROCTER & GAMBLE (US) 2026-04-15 EP disclosed
EP-4719337-A1 COMPOSITIONS HAVING LOW LEVELS OF SURFACTANTS AND ENHANCED DEPOSITION OF SCALP CARE ACTIVES The Procter & Gamble Company (US) 2026-04-08 EP disclosed
EP-4171483-B1 DISSOLVABLE SOLID FIBROUS ARTICLES CONTAINING ANIONIC SURFACTANTS PROCTER & GAMBLE (US) 2026-04-08 EP disclosed
EP-4349950-B1 FABRIC CARE COMPOSITION PROCTER & GAMBLE (US) 2026-03-25 EP disclosed
WO-2006113658-A2 DILUTE FABRIC CARE COMPOSITIONS COMPRISING THICKENERS AND FABRIC CARE COMPOSITIONS FOR USE IN THE PRESENCE OF ANIONIC CARRY-OVER THE PROCTER & GAMBLE COMPANY (US) 2006-10-26 WO disclosed
WO-2006063092-A1 FABRIC ENHANCING COMPOSITION THE PROCTER & GAMBLE COMPANY (US) 2006-06-15 WO disclosed
US-20060122094-A1 Fabric enhancing composition PROCTER & GAMBLE COMPANY, THE 2006-06-08 US disclosed
WO-2006044875-A1 CONCENTRATED FABRIC SOFTENER ACTIVE COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 2006-04-27 WO disclosed
US-20060089293-A1 Concentrated fabric softener active compositions PROCTER & GAMBLE COMPANY, THE 2006-04-27 US disclosed
WO-2006014416-A1 PERSONAL CARE COMPOSITIONS CONTAINING CATIONICALLY MODIFIED STARCH AND AN ANIONIC SURFACTANT SYSTEM THE PROCTER & GAMBLE COMPANY (US) 2006-02-09 WO disclosed
US-20060002880-A1 Personal care compositions containing cationically modified starch and an anionic surfactant system THE PROCTER & GAMBLE COMPANY 2006-01-05 US disclosed
EP-1606373-A1 FABRIC CARE COMPOSITIONS COMPRISING CATIONIC STARCH THE PROCTER & GAMBLE COMPANY (US) 2005-12-21 EP disclosed
WO-2004087854-A1 FABRIC CARE COMPOSITIONS COMPRISING CATIONIC STARCH THE PROCTER & GAMBLE COMPANY (US) 2004-10-14 WO disclosed
US-20040204337-A1 Fabric care compositions comprising cationic starch THE PROCTER & GAMBLE COMPANY 2004-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060002880-A1 Personal care compositions containing cationically modified starch and an anionic surfactant system CUTA, SGMS1, SGMS2 SMPD1 644/4885FDPS 4813/4885GGPS1 4502/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.